<DOC>
	<DOCNO>NCT02684045</DOCNO>
	<brief_summary>The purpose chart review ass outcomes subject receive MAGNIFUSE posterolateral lumbar spine 1 2 continuous level L1-S1 .</brief_summary>
	<brief_title>Retrospective Chart Review Assess Outcomes Subjects That Received MAGNIFUSEÂ® Posterolateral Lumbar Spine</brief_title>
	<detailed_description />
	<criteria>A subject 's medical record must contain follow subject include : 1 . Posterolateral surgical procedure use MAGNlFUSE local autograft and/or iliac crest bone graft one two continuous lumbar level L1S1 . 2 . Radiographs available fusion assessment clinician 12 and/or 24 month postsurgery visit . 3 . Subject must least 18 year old time index procedure . The subject data exclude study medical record indicate : 1 . Additional surgical treatment adjacent initial lumbar level treat per Inclusion Criterion 1 . 2 . Infection index level ( ) time surgery . 3 . Extant tumor ( evident level ) , spinal metastasis , spinal tumor time surgery . 4 . Pregnant time surgery . 5 . Surgery due trauma ( e.g. , motor vehicle accident high impact fall ) . 6 . Use growth factor growth peptide ( BMP2 , BMP7 , iFactor ) indexlevel fusion surgery . 7 . Procedure revision surgery previously fail fusion surgery index level ( ) . 8 . Subjects body mass index &gt; 40 time surgery .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>